Cambridge Cancer Genomics' Seed Round

Cambridge Cancer Genomics raised a round of funding on August 22, 2017. Investors include Y Combinator.

Cambridge Cancer Genomics uses artificial neural networks and machine learning algorithms to design personalized tests for tracking treatment response in cancer patients. By applying its proprietary a…

Articles about Cambridge Cancer Genomics' Seed Round: